Meir Medical Center
Welcome,         Profile    Billing    Logout  
 52 Trials 
16 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Avital, Shmuel
ITCORA, NCT03316677: Intraoperative Testing of Colorectal Anastomosis - Air or Water (Methylene Blue)?

Not yet recruiting
N/A
150
NA
Intraoperative testing of colorectal anastomoses, Stapled colorectal anastomoses
Meir Medical Center
ColoRectal Cancer, Colonic Diverticulitis, Anastomotic Leak, Anastomotic Complication, Anastomosis
12/19
12/22
Brin, Yaron
NCT05618808: A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult Participants

Completed
2
373
Europe, Canada
REGN9933, Enoxaparin, Lovenox, Apixiban, Eliquis
Regeneron Pharmaceuticals
Venous Thromboembolism
05/24
05/24
Haim, Moti
BIO|STREAM HF, NCT03366545: Observation of Clinical Routine Care for Heart Failure Patients Implanted With BIOTRONIK CRT Devices

Recruiting
N/A
3000
Europe, Japan, RoW
Cardiac Resynchronization Therapy (CRT)
Biotronik SE & Co. KG
Heart Failure
12/24
06/25
Levy, Yair
TOPAZ-2, NCT04961567 / 2020-005776-35: A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus

Recruiting
3
540
Europe, Canada, Japan, US, RoW
Litifilimab, BIIB059, Placebo
Biogen
Lupus Erythematosus, Systemic
09/25
03/26
BLISSc-ILD, NCT05878717: A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

Hourglass Jan 2021 - Jun 2021 : Submission in combination with rituximab for SLE
Recruiting
3
300
Europe, Canada, Japan, US, RoW
Belimumab, BENLYSTA™, GSK1550188, LymphoStat-B™, BENLYSTATM, GSK1550188, LymphoStat-B™, Placebo
GlaxoSmithKline
Systemic Sclerosis Associated Interstitial Lung Disease, Scleroderma, Systemic
02/27
02/27
NCT04781543 / 2020-005764-62: A Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic Sclerosis

Calendar Jan 2024 - Dec 2024: Data from trial for diffuse cutaneous systemic sclerosis
Recruiting
2
300
Europe, Japan, US, RoW
HZN-825 BID, Placebo, HZN-825 QD
Amgen
Diffuse Cutaneous Systemic Sclerosis, Sclerosis, Systemic
10/24
09/25
NCT05540665 / 2022-001377-31: Study of Daxdilimab (HZN-7734) in Participants With Active Proliferative Lupus Nephritis (LN)

Terminated
2
19
Europe, US, RoW
Daxdilimab, Placebo (Normal Saline)
Amgen, Horizon Therapeutics Ireland DAC
Lupus Nephritis
01/24
01/24
NCT03473912: Meir Medical Center Rheumatologic Biobank

Recruiting
N/A
500
RoW
Meir Medical Center
Rheumatoid Arthritis, Lupus Erythematosus, Systemic, Systemic Sclerosis, IgG4-related Disease, Sjogren's Syndrome
11/37
11/37
Szabo, István
NCT05618808: A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult Participants

Completed
2
373
Europe, Canada
REGN9933, Enoxaparin, Lovenox, Apixiban, Eliquis
Regeneron Pharmaceuticals
Venous Thromboembolism
05/24
05/24
Kuchuk, Iryna
postMONARCH, NCT05169567 / 2021-002301-10: Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer

Active, not recruiting
3
368
Europe, US, RoW
Abemaciclib, Fulvestrant, Placebo
Eli Lilly and Company, Eli Lilly and Company
Breast Neoplasm, Neoplasm Metastasis
02/24
02/26
EMBER-4, NCT05514054: A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer

Recruiting
3
6000
Europe, Canada, Japan, US, RoW
Imlunestrant, LY3484356, Tamoxifen, Anastrozole, Letrozole, Exemestane
Eli Lilly and Company
Breast Neoplasms
10/27
03/32
Norman, Doron
NCT05618808: A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult Participants

Completed
2
373
Europe, Canada
REGN9933, Enoxaparin, Lovenox, Apixiban, Eliquis
Regeneron Pharmaceuticals
Venous Thromboembolism
05/24
05/24
NCT03024008: Enhancement of Bone Regeneration and Healing in the Extremities by the Use of Autologous BonoFill-II

Recruiting
1/2
20
RoW
BonoFill-II
BonusBio Group Ltd
Bone Fracture
06/22
09/22
Berla, Maya
CLL17, NCT04608318 / 2019-003854-99: Ibrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients With Previously Untreated Chronic Lymphocytic Leukaemia (CLL)

Active, not recruiting
3
897
Europe, RoW
Ibrutinib, Imbruvica, Venetoclax, ABT-199, Venclyxto, Obinutuzumab, GA101, Gazyvaro
German CLL Study Group, Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON), Nordic CLL Study Group (NCLLSG), Swiss Group for Clinical Cancer Research (SAKK), Cancer Trials Ireland, Gruppo Italiano Malattie EMatologiche dell'Adulto (GIMEMA), Grupo Español de Leucemia Linfocítica Crónica (GELLC), The Israeli CLL Study Group (ICLLSG)
Chronic Lymphoid Leukemia
03/27
03/27
Samson, Laszlo
NCT05618808: A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult Participants

Completed
2
373
Europe, Canada
REGN9933, Enoxaparin, Lovenox, Apixiban, Eliquis
Regeneron Pharmaceuticals
Venous Thromboembolism
05/24
05/24
Janositz, Gabor
NCT05618808: A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult Participants

Completed
2
373
Europe, Canada
REGN9933, Enoxaparin, Lovenox, Apixiban, Eliquis
Regeneron Pharmaceuticals
Venous Thromboembolism
05/24
05/24

Download Options